Skip to main content

CORRECTION article

Front. Oncol., 18 September 2023
Sec. Gastrointestinal Cancers: Colorectal Cancer
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1283480

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

This article is a correction to:

  1. Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy

    1. Read original article
Shuai YeShuai Ye1Yu HanYu Han2XiMin PanXiMin Pan1KeXin NiuKeXin Niu1YuTing LiaoYuTing Liao3XiaoChun Meng*XiaoChun Meng1*
  • 1The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 2The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 3GE Healthcare Pharmaceutical Diagnostics, Guangzhou, China

A Corrigendum on
Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy

by Ye S, Han Y, Pan XM, Niu KX, Liao YT and Meng XC (2022) Front. Oncol. 12:843991. doi: 10.3389/fonc.2022.843991

Text Correction

In the published article, there was an error. A correction was made to Author contributions. In the published original article this section previously stated:

“SY: Formal analysis, Investigation, Writing - original draft. YH: Investigation KXN: Investigation YTL: Methodology, Software. XCT: Conceptualization, Supervision, writing – review and editing. XMP participated in data collection, data analyses, software, and interpretation. All authors contributed to the article and approved the submitted version”.

The corrected version appears below:

“SY, YH and XP are co-authors. SY: Formal analysis, Investigation, Writing - original draft. YH: Investigation KN: Investigation YL: Methodology, Software. XCM: Conceptualization, Supervision, writing – review and editing. XP participated in data collection, data analyses, software, and interpretation. All authors contributed to the article and approved the submitted version”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: radiomics, computed tomography, progression-free survival, colorectal liver metastases, chemotherapy

Citation: Ye S, Han Y, Pan XM, Niu KX, Liao YT and Meng XC (2023) Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy. Front. Oncol. 13:1283480. doi: 10.3389/fonc.2023.1283480

Received: 26 August 2023; Accepted: 05 September 2023;
Published: 18 September 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Ye, Han, Pan, Niu, Liao and Meng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: XiaoChun Meng, bWVuZ3hjaDNAbWFpbC5zeXN1LmVkdS5jbg==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.